The chemokine/chemokine-receptor family: Potential and progress for therapeutic intervention

Current Opinion in Chemical Biology

Volumn 4, Issue 4, 2000, Pages 420-427

  Cascieri, Margaret A ^a   Springer, Martin S ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2 BROMOPHENYL) 3 (2 HYDROXY 4 NITROPHENYL)UREA; 1 [5 CHLORO 2 [2 [4 (4 FLUOROBENZYL) 2 METHYL 1 PIPERAZINYL] 2 OXOETHOXY]PHENYL]UREA; 1,1' [1,4 PHENYLENEBIS(METHYLENE)]BIS(1,4,8,11 TETRAAZACYCLOTETRADECANE); ALANINE; CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR5; G PROTEIN COUPLED RECEPTOR; GLUTAMINE; N [4 [[[6,7 DIHYDRO 2 (4 METHYLPHENYL) 5H BENZOCYCLOHEPTEN 8 YL]CARBONYL]AMINO]BENZYL] N,N DIMETHYL 2H TETRAHYDROPYRAN 4 AMINIUM CHLORIDE; NEUTRALIZING ANTIBODY; PIPERIDINE DERIVATIVE; RECEPTOR BLOCKING AGENT; RS 511336000; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIVIRAL ACTIVITY; DELAYED HYPERSENSITIVITY; DRUG TARGETING; GRAFT REJECTION; INFLAMMATORY DISEASE; LEUKOCYTE MIGRATION; MULTIPLE SCLEROSIS; NONHUMAN; REVIEW; RHEUMATOID ARTHRITIS; TREATMENT OUTCOME;

EID: 0033868651     PISSN: 13675931     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1367-5931(00)00113-7     Document Type: Review

References (94)

1. Chemokines - chemotactic cytokines that mediate inflammation
2. Chemokines. Introduction and overview
3. Structure and functional expression of a human interleukin-8 receptor
4. Cloning of complementary DNA encoding a functional human interleukin-8 receptor
5. Human Mig chemokine: Biochemical and functional characterization
6. Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1
7. Dominant myelopoietic effector functions mediated by chemokine receptor CCR1
8. The role of CXC chemokines as regulators of angiogenesis
9. The role of CXC chemokines in the regulation of angiogenesis
10. A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen
11. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1
12. Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice
13. Eotaxin influences the development of embryonic hematopoietic progenitors in the mouse
14. The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract
15. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development
16. Utilization of chemokine receptors, orphan receptors, and herpesvirus-encoded receptors by diverse human and simian immunodeficiency viruses
17. The interleukin-8 receptor family: From chemokines to malaria
18. Chemokine receptors: Roles in viral entry, tropism, and disease
19. International union of pharmacology. XXII. Nomenclature for chemokine receptors
20. Identification of CCR8, the receptor for the human CC chemokine I-309
21. Identification of CCR8 as the specific receptor for the human beta-chemokine I-309: Cloning and molecular characterization of murine CCR8 as the receptor for TCA-3
22. Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor
23. Structure and functional expression of the human macrophage inflammatory protein 1 alpha/RANTES receptor
24. Chemokine receptor specific for IP10 and mig: Structure, function, and expression in activated T-lymphocytes
25. Interferon-inducible T cell alpha chemoattractant (I-TAC): A novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3
26. Binding and functional properties of recombinant and endogenous CXCR3 chemokine receptors
27. Functional and biochemical analysis of the cloned Duffy antigen: Identify with the red blood cell chemokine receptor
28. Cloning, expression, and chromosomal mapping of a novel human CC-chemokine receptor (CCR10) that displays high-affinity binding for MCP-1 and MCP-3
29. Cloning and characterization of a novel promiscuous human beta-chemokine receptor D6
30. Cloning, expression, and characterization of the human eosinophil eotaxin receptor
31. Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils
32. Molecular cloning and functional expression of a new human CC-chemokine receptor gene
33. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s
34. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes
35. Assessment of chemokine receptor expression by human Th1 and Th2 cells in vitro and in vivo
36. Intraallograft chemokine RNA and protein during rejection of MHC-Matched/Multiple minor histocompatibility-disparate skin grafts
37. Deletion of CCR8 attenuates eosinophil accumulation, Th2 cytokine production and airway hyperreactivity in a cockroach allergen model of asthma
38. Discovery of novel non-peptide CCR1 receptor antagonists
39. Identification and characterization of a potent, selective and orally active antagonist of the CC chemokine receptor-1
40. Identification of the binding site for a novel class of CCR2b chemokine receptor antagonists: Binding to a common chemokine receptor motif within the helical bundle
41. A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity
42. Discovery of novel, potent, and selective small-molecule CCR5 antagonists as anti-HIV-1 agents: Synthesis and biological evaluation of anilide derivatives with a quaternary ammonium moiety
43. Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neutrophil migration
44. AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor
45. Inhibition of HIV infection by bicyclams, highly potent and specific CXCR4 antagonists
46. A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5
47. Identification of critical functional groups within binding pockets of G-protein-coupled receptors
48. Dual personality of memory T cells
49. The chemokine SDF-1 stimulates integrin-mediated arrest of CD34(+) cells on vascular endothelium under shear flow
50. A cell-autonomous requirement for CXCR4 in long-term lymphoid and myeloid reconstitution
51. The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow microenvironment
52. Increased chemokine receptor CCR7/EBI1 expression enhances the infiltration of lymphoid organs by adult T-cell leukemia cells
53. The CC chemokine thymus-derived chemotactic agent 4 (TCA-4, secondary lymphoid tissue chemokine, 6Ckine, exodus-2) triggers lymphocyte function-associated antigen 1-mediated arrest of rolling T lymphocytes in peripheral lymph node high endothelial venules
54. The role of chemokines in the microenvironmental control of T versus B cell arrest in Peyer's patch high endothelial venules
55. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions
56. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells
57. Human G protein-coupled receptor GPR-9-6/CC chemokine receptor 9 is selectively expressed on intestinal homing T lymphocytes, mucosal lymphocytes, and thymocytes and is required for thymus-expressed chemokine-mediated chemotaxis
58. Monocyte chemoattractant protein 1-dependent leukocytic infiltrates are responsible for autoimmune disease in MRL-Fas(lpr) mice
59. Effect of C-C chemokine receptor 2 (CCR2) knockout on type-2 (schistosomal antigen-elicited) pulmonary granuloma formation: Analysis of cellular recruitment and cytokine responses
60. Defects in the generation of IFN-gamma are overcome to control infection with Leishmania donovani in CC chemokine receptor (CCR) 5-, macrophage inflammatory protein-1 alpha-, or CCR2-deficient mice
61. CCR2 expression determines T1 versus T2 polarization during pulmonary Cryptococcus neoformans infection
62. Adenoviral-mediated overexpression of monocyte chemoattractant protein-1 differentially alters the development of Th1 and Th2 type responses in vivo
63. Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1
64. CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1 alpha and IP-10 are expressed in demyelinating brain lesions
65. Sentries at the gate: Chemokines and the blood-brain barrier
66. CCR5 delta32, matrix metalloproteinase-9 and disease activity in multiple sclerosis
67. Targeting of chemokine receptors CCR2 and CCr5 prolongs murine cardiac allograft survival
68. Active participation of CCR5(+)CD8(+) T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease
69. T cell infiltration into class II MHC-disparate allografts and acute rejection is dependent on the IFN-gamma-induced chemokine Mig
70. CC CKR5: A RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1
71. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates
72. Identification of a major co-receptor for primary isolates of HIV-1
73. A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors
74. HIV-1 entry into CD4(+) cells is mediated by the chemokine receptor CC-CKR-5
75. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor
76. Molecular cloning and functional characterization of a novel human CC chemokine receptor (CCR5) for RANTES, MIP-1beta, and MIP-1alpha
77. Characterization of conserved human immunodeficiency virus type 1 gp 120 neutralization epitopes exposed upon gp120-CD4 binding
78. The antigenic structure of the HIV gp120 envelope glycoprotein
79. Conformation changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding
80. CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5
81. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5
82. A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding
83. Evidence for cell-surface association between fusin and the CD4-gp120 complex in human cell lines
84. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study
85. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression
86. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection
87. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene
88. Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: Studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk
89. A small molecule antagonist of CCR5 that effectively inhibits HIV-1-potential as a novel antiretroviral agent
90. Discovery of Potent Human CCR5 Antagonists for the Treatment of HIV-1 Infection - 1
91. Discovery of potent human CCR5 antagonists for the treatment of HIV-1 infection - 4
92. Bicyclams as CXCR4 antagonists
93. Marked increase in anti-HIV activity, as well as inhibitory activity against HIV entry mediated by CXCR4, linked to enhancement of the binding ability of tachyplesin analogs to CXCR4
94. Inhibitory mechanism of the CXCR4 antagonist T22 against human immunodeficiency virus type 1 infection